ALAN LESHNER (Chair), American Association for the Advancement of Science
HUDA AKIL, University of Michigan
MARC BARLOW, GE Healthcare, Inc.
MARK BEAR, Massachusetts Institute of Technology
DAVID BREDT, Eli Lilly and Company
DANIEL BURCH, CeNeRx Biopharma
DENNIS CHOI, Simons Foundation (until March 2011)
TIMOTHY COETZEE, National Multiple Sclerosis Society
DAVID COHEN, Columbia University
JOHN DUNLOP, Pfizer Inc.
EMMELINE EDWARDS, NIH Neuroscience Blueprint
RICHARD FRANK, GE Healthcare, Inc.
MYRON GUTTMAN, National Science Foundation
RICHARD HODES, National Institute on Aging
KATIE HOOD, Michael J. Fox Foundation for Parkinson's Research
STEVEN E. HYMAN, Harvard University
THOMAS INSEL, National Institute of Mental Health
DANIEL JAVITT, Nathan Kline Institute for Psychiatric Research
STORY LANDIS, National Institute of Neurological Disorders and Stroke
HUSSEINI MANJI, Johnson & Johnson Pharmaceutical Research and Development, LLC
EVE MARDER, Brandeis University
DAVID MICHELSON, Merck Research Laboratories
JONATHAN MORENO, University of Pennsylvania School of Medicine
KATHIE L. OLSEN, Association of Public and Land-Grant Universities
ATUL PANDE, GlaxoSmithKline, Inc.
MENELAS PANGALOS, AstraZeneca Pharmaceuticals
STEVEN PAUL, Weill Cornell Medical College
WILLIAM POTTER, FNIH Neuroscience Biomarker Steering Committee
PAUL SIEVING, National Eye Institute
RAE SILVER, Columbia University
JUDITH SIUCIAK, Foundation for the National Institutes of Health
MARC TESSIER-LAVIGNE, Rockefeller University
WILLIAM THIES, Alzheimer's Association
NORA VOLKOW, National Institute on Drug Abuse
KENNETH WARREN, National Institute on Alcohol Abuse and Alcoholism
FRANK YOCCA, AstraZeneca Pharmaceuticals
STEVIN H. ZORN, Lundbeck USA
CHARLES ZORUMSKI, Washington University School of Medicine
BRUCE M. ALTEVOGT, Forum Director
SARAH L. HANSON, Associate Program Officer (until June 2010)
DIANA E. PANKEVICH, Associate Program Officer (since October 2010)
LORA K. TAYLOR, Senior Project Assistant
ANDREW POPE, Director, Board on Health Sciences Policy
Institute of Medicine forums and roundtables do not issue, review, or approve individual documents. The responsibility for the published workshop summary rests with the workshop rapporteurs and the institution.
National Academies Press (US), Washington (DC)
Institute of Medicine (US) Forum on Neuroscience and Nervous System Disorders. Glutamate-Related Biomarkers in Drug Development for Disorders of the Nervous System: Workshop Summary. Washington (DC): National Academies Press (US); 2011. INSTITUTE OF MEDICINE FORUM ON NEUROSCIENCE AND NERVOUS SYSTEM DISORDERS.